Business Context and Reporting Period
Company: James Hardie Industries Plc (JHI NV)
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended March 31, 2005
Business Overview: JHI NV is the largest manufacturer of fiber cement building products in the United States, Australia, New Zealand, and the Philippines. The company operates primarily in the USA Fiber Cement, Asia Pacific Fiber Cement, and Other (Chile, Europe, USA Pipes, Roofing) segments. The company is incorporated in The Netherlands and lists its securities on the Australian Stock Exchange (ASX) and the New York Stock Exchange (NYSE).
Key Financial Metrics
| Metric | Fiscal 2005 | Fiscal 2004 | Change |
|---|---|---|---|
| Total Net Sales | $1,210.4 million | $981.9 million | +23% |
| Operating Income | $196.2 million | $172.2 million | +14% |
| Income from Continuing Operations | $127.9 million | $125.3 million | +2% |
| Net Income | $126.9 million | $129.6 million | -2% |
| Diluted EPS (Continuing Ops) | $0.28 | $0.27 | + |
| Adjusted EBITDA | $232.5 million | $208.6 million | +11% |
| Operating Cash Flow | $219.8 million | $162.6 million | +35% |
| Capital Expenditures | $153.0 million | $74.1 million | +106% |
| Long-Term Debt | $147.4 million | $165.0 million | -11% |
| Cash and Cash Equivalents | $113.5 million | $72.3 million | +57% |
| Shareholders' Equity | $624.7 million | $504.7 million | +24% |
Material Changes vs. Prior Period
- Revenue Growth: Total net sales increased 23% driven by a 27% increase in USA Fiber Cement sales (due to volume and price increases) and a 7% increase in Asia Pacific sales (driven by favorable currency and volume in the Philippines).
- SCI and Related Expenses: The company incurred $28.1 million in expenses related to the Special Commission of Inquiry (SCI) into the establishment of the Medical Research and Compensation Foundation. This included $6.8 million for the SCI itself, $4.9 million for internal investigations, and $6.0 million in severance/consulting for former executives.
- Capital Expenditures: Capital spending more than doubled to $153.0 million, primarily to fund the construction of a new plant in Pulaski, Virginia, and capacity expansions in the USA (Reno, Nevada; Peru, Illinois; Blandon, Pennsylvania).
- Management Changes: Following the SCI report, former CEO Peter Macdonald and former CFO Peter Shafron resigned in October 2004. Louis Gries was appointed CEO and Russell Chenu was appointed CFO in early 2005.
Guidance, Outlook, Risks, and Contingencies
Asbestos Liability and the "Principal Agreement"
The most significant risk facing the company is potential liability for asbestos-related claims against former subsidiaries (Amaca, Amaba, and ABN 60). The NSW Government's Special Commission of Inquiry (SCI) found a significant funding shortfall in the Foundation established to pay these claims.
- Heads of Agreement: On December 21, 2004, JHI NV entered into a non-binding Heads of Agreement with the NSW Government and union representatives to establish a Special Purpose Fund (SPF) to compensate claimants.
- Principal Agreement: Negotiations for a binding "Principal Agreement" were ongoing as of the filing date. If executed, the company may be required to make substantial annual payments to the SPF, capped initially at 35% of annual net operating cash flow.
- Legislative Risk: If negotiations fail, the NSW Government has indicated it may pass legislation to impose retroactive liability on JHI NV for asbestos claims.
- Financial Impact: The company has not recorded a provision for asbestos liabilities as of March 31, 2005, because the obligation is not yet considered "probable and estimable" under U.S. GAAP. However, the company acknowledges that if the Principal Agreement is signed, it could materially adversely affect financial position and cash flows.
Outlook
- USA Market: Short-term outlook remains positive due to strong housing starts and low interest rates, though growth rates are expected to moderate compared to fiscal 2005.
- Asia Pacific: No improvement expected in new housing activity in Australia and New Zealand in the short term. Product bans and boycotts related to the SCI are expected to lift progressively.
- Capital Needs: The company expects to spend up to $175 million on capital expenditures in fiscal 2006. It believes current cash and credit facilities are sufficient to fund operations and potential initial asbestos payments, but may need to seek additional borrowing if the Principal Agreement requires significant funding.
Other Risks
- Taxation: Changes to the U.S.-Netherlands tax treaty could increase the company's effective tax rate if it fails to meet new eligibility requirements.
- Competition: Intense competition in the building products industry, particularly in Australia and New Zealand, could pressure prices and margins.
- Raw Materials: Fluctuations in the price of cellulose fiber (pulp) could impact costs.
Key Facts for Investor Verification
- Asbestos Funding Status: Verify the final terms of the "Principal Agreement" with the NSW Government and the specific annual payment caps and duration.
- Legislative Action: Monitor whether the NSW Government passes legislation imposing retroactive liability if the Principal Agreement is not finalized.
- Debt Refinancing: Confirm the successful renewal of credit facilities (specifically the $355 million in new facilities entered into in June 2005) and whether they are extended to five-year terms contingent on the asbestos agreement.
- USA Housing Market: Track U.S. housing starts and interest rates, as the U.S. segment contributes approximately 78% of total net sales.
- Capital Expenditure Execution: Verify the completion timeline and cost of the new Pulaski, Virginia plant and other capacity expansions.